Con-Way Beats Dahlman Rose & Co. Estimate

Con-Way, Inc.

reported 3Q10 EPS from continuing operations of $0.22, “beating our estimate of $0.21 and below consensus of $0.26,” Dahlman Rose & Co. reports. “Despite the earnings miss to consensus, we believe investors' focus on improved pricing provided a boost to shares. We continue to recommend CNW shares, but only for long term investors,” Dahlman Rose & Co. writes. “We are maintaining our 2010 and 2011 EPS estimates of $0.70 and $2.45, respectively.” Dahlman Rose & Co. said that its $36 price target remains unchanged. Con-Way currently trades at $34.87.